CuriGraft® Viable Allogenic Bone Matrix is the next generation allograft containing the three key elements ideal for bone formation, offering a variety of clinical applications, including the spine, upper extremity, foot and ankle and orthopedic oncology.
Key Features
-
-
- Osteoconductive three-dimensional scaffold with cortical and cancellous components
- Demineralized cortical bone scaffold. Demineralized cortical bone has been identified to have osteoinductive potential1
- Viable endogenous bone cells to support osteogenic healing processes
- DMSO-FREE cryoprotectant, requiring no rinsing or decanting
- Proprietary mixture of mineralized cancellous bone along with demineralized cortical fibers
- Easy-to-use syringe, just thaw and use!
- Four-hour working window for implantation post thaw
- Storage: -65°C or colder
Size |
Product Code |
1.0cc |
C034-0001-MCBMV |
2.5cc |
C034-0025- MCBMV |
5.0cc |
C034-0005- MCBMV |
10.0cc |
C034-0010- MCBMV |
Reference: 1) Gruskin, E. et.al., Demineralized bone matrix in bone repair: history and use. Advanced Drug Delivery Reviews, 2012. 64:1063-1077 Biologics